In a recent study published by Nature Communications, researchers uncovered a previously unknown method by which androgen-activated androgen receptors (ARs) increase fucosyltransferase 4 (FUT4) ...

Clinical Implications of a Large-Scale Voluntary Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine: Preliminary Results The following represents disclosure ...

A TTUHSC research team led by Srinivas Nandana, Ph.D., (center) and Manisha Tripathi, Ph.D., (left) recently completed a study focused on uncovering the molecular and signaling mechanisms that drive ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

The dinuclear platinum(II) complexes inhibit prostate cancer cell growth by binding to the androgen receptor (AR) and disrupting AR-mediated gene expression. This mechanism leads to apoptosis and ...

Reduced-dose ARSI therapy in non-metastatic castration-resistant prostate cancer has similar efficacy and safety as the full dose.

A meta-analysis involving 21,260 patients with advanced or metastatic prostate cancer confirms increased risks of falls and fractures with the addition of androgen receptor signaling inhibitors to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The addition of ...

“Nothing Is as Great a Learning Experience as Getting a $15,000 Bill”: A Mixed-Methods Study of Young Adult Cancer Survivors' Experience With Insurance Coverage The following represents disclosure ...